Hpc Biosciences Limited announced unaudited earnings results for the six months ended September 30, 2018. For the half year, the company reported total revenue of INR 40.54 million against INR 76.40 million a year ago. Loss before exceptional and extraordinary items and tax were INR 16.11 million against profit before exceptional and extraordinary items and tax INR 21.22 million a year ago. Loss before tax was INR 16.11 million compared to profit before tax INR 21.22 million a year ago. Loss for the period was INR 18.06 million against profit for the period INR 21.22 million a year ago.